BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21194671)

  • 1. Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Meng MB; Wen QL; Cui YL; She B; Zhang RM
    Explore (NY); 2011; 7(1):37-43. PubMed ID: 21194671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
    Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
    Meng MB; Cui YL; Guan YS; Ying Z; Zheng MH; Yuan CK; Zhang RM
    J Altern Complement Med; 2008 Oct; 14(8):1027-42. PubMed ID: 18990050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis of the efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in treating unresectable primary liver cancer].
    Gu GW; Li XC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):805-9. PubMed ID: 19595117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis.
    Ramsey DE; Geschwind JF
    Tech Vasc Interv Radiol; 2002 Sep; 5(3):122-6. PubMed ID: 12524642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
    Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoembolization of hepatocellular carcinoma: results of a metaanalysis.
    Geschwind JF; Ramsey DE; Choti MA; Thuluvath PJ; Huncharek MS
    Am J Clin Oncol; 2003 Aug; 26(4):344-9. PubMed ID: 12902882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
    Tian G; Liu J; Zhou JS; Chen W
    Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
    Morimoto M; Numata K; Kondou M; Nozaki A; Morita S; Tanaka K
    Cancer; 2010 Dec; 116(23):5452-60. PubMed ID: 20672352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM; Qin H; Wang CB; Fang XH; Ma QY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS
    Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
    Giannini EG; Bodini G; Corbo M; Savarino V; Risso D; Di Nolfo MA; Del Poggio P; Benvegnù L; Farinati F; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Aliment Pharmacol Ther; 2010 Feb; 31(4):493-501. PubMed ID: 19912152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.